Professor Gilhooley came to Seton Hall Law School in 1981 and has taught Food and Drug Law, Drug Innovation Regulation and Costs, Administrative Law and Torts. She has published in the areas of Administrative Law, and Food and Drug Law. She was appointed by President Clinton to the Commission on Dietary Supplement Labels. She testified before the House Committee on Government Reform on issues concerning dietary supplements and health claims. Professor Gilhooley received her undergraduate degree from Fordham University, magna cum laude, and her law degree from Columbia University, magna cum laude, where she was a member of the Law Review. In addition to practicing law at Debevoise & Plimpton, she was an associate Chief Counsel for the U.S. Food and Drug Administration, an attorney and consultant for the Administrative Conference of the United States and an Attorney for the U.S. Office of Economic Opportunity. She has served as a member of the Council of Administrative Law Section of the American Bar Association, and as a member of the editorial board of the Food and Drug Law Journal. She was a member of the Committee on Academic Freedom and Tenure of the Association of American Law Schools, and of the AALS Special Committee on the Ethical and Professional Responsibilities of Law Professors. She is an elected member of the American Law Institute.

Drug Preemption and the Need to Reform the FDA Consultation Process, 34 Amer. J. of Law & Med., 535 (2008).

Addressing Potential Drug Risks: The Limits of Testing, Risk Signals, Preemption, and the Drug Reform Legislation, 59 South Carolina Law Review, 347 (2008).

Vioxx's History and the Need for Better Procedures and Better Testing, 37 Seton Hall L. Rev. 941(2007).

Heal the Damage: Prescription Drug Consumer Advertisements and Relative Choices, 38 Health L. J. 1 (2005)

The Impact and Limits of the Constitutional Deregulation of Health Claims on Foods and Supplements: From Dementia to Nuts to Chocolate to Saw Palmetto, 56 Mercer L. Rev. 683 (2005)